Literature DB >> 2658769

Bioactivation in chemical teratogenesis.

M R Juchau1.   

Abstract

Within the past decade, interest has increased markedly in the elucidation of mechanisms whereby drugs and other chemicals can alter the normal developmental pattern of the developing conceptus. This has, in large measure, been attributable to the recent availability of methods for the successful long-term culture of whole embryos as well as various embryonic tissues (e.g. limb buds). These preparations have enabled a more straightforward investigation of the direct effects of chemicals on the conceptus per se, without the complicating and frequently confounding participation of maternal factors. The demonstration that exogenous metabolic preparations could be incorporated into such culture systems has enabled investigators to pursue questions about the nature of proximate and ultimate chemical species responsible for producing abnormal morphogenesis. Demonstrations of the capacity of the early conceptus to effect profound dysmorphogenic bioactivation provide additional relevance to such questions. Elucidation of the identity of the chemical species represents a first and necessary step in unravelling the pathogenic mechanism. Control of their rates of generation and inactivation or elimination are probable major determinants of incidence/severity of chemically induced embryotoxicity. Future investigations of these phenomena promise to yield key contributions to the discovery of mechanisms in chemical teratogenesis.

Mesh:

Substances:

Year:  1989        PMID: 2658769     DOI: 10.1146/annurev.pa.29.040189.001121

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  8 in total

1.  Implication of C-5, C-6 unsaturation as a key structural factor in steroidal alkaloid-induced mammalian teratogenesis.

Authors:  W Gaffield; R F Keeler
Journal:  Experientia       Date:  1993-10-15

2.  Increased sensitivity to testicular toxicity of transplacental benzo[a]pyrene exposure in male glutamate cysteine ligase modifier subunit knockout (Gclm-/-) mice.

Authors:  Brooke N Nakamura; Isaac Mohar; Gregory W Lawson; Mabel M Cortés; Yvonne D Hoang; Laura Ortiz; Reshma Patel; Bogdan A Rau; Lisa A McConnachie; Terrance J Kavanagh; Ulrike Luderer
Journal:  Toxicol Sci       Date:  2012-01-17       Impact factor: 4.849

Review 3.  The role of active metabolites in drug toxicity.

Authors:  M Pirmohamed; N R Kitteringham; B K Park
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

4.  The transcription factor, Nuclear factor, erythroid 2 (Nfe2), is a regulator of the oxidative stress response during Danio rerio development.

Authors:  Larissa M Williams; Briony A Lago; Andrew G McArthur; Amogelang R Raphenya; Nicholas Pray; Nabil Saleem; Sophia Salas; Katherine Paulson; Roshni S Mangar; Yang Liu; Andy H Vo; Jordan A Shavit
Journal:  Aquat Toxicol       Date:  2016-10-01       Impact factor: 4.964

Review 5.  Methods to identify and characterize developmental neurotoxicity for human health risk assessment. III: pharmacokinetic and pharmacodynamic considerations.

Authors:  D C Dorman; S L Allen; J Z Byczkowski; L Claudio; J E Fisher; J W Fisher; G J Harry; A A Li; S L Makris; S Padilla; L G Sultatos; B E Mileson
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

6.  2-(3,4-Di-meth-oxy-phen-yl)-1-pentyl-4,5-diphenyl-1H-imidazole.

Authors:  Shaaban K Mohamed; Mehmet Akkurt; Adel A Marzouk; Kuldip Singh; Mustafa R Albayati
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-11-27

7.  Evaluation of Optimal Post-Injection Timing of Hypoxic Imaging with 18F-Fluoromisonidazole-PET/CT.

Authors:  Mitsue Kawamura; Michio Yoshimura; Yoichi Shimizu; Kohei Sano; Takayoshi Ishimori; Yuji Nakamoto; Takashi Mizowaki; Masahiro Hiraoka
Journal:  Mol Imaging Biol       Date:  2021-01-21       Impact factor: 3.488

8.  Transplacental transfer of genotoxins and transplacental carcinogenesis.

Authors:  H Autrup
Journal:  Environ Health Perspect       Date:  1993-07       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.